Cargando…
Progress in molecular feature of smoldering mantle cell lymphoma
Mantle cell lymphoma (MCL) is considered one of the most aggressive lymphoid tumors. However, it sometimes displays indolent behavior in patients and might not necessitate treatment at diagnosis; this has been described as “smoldering MCL” (SMCL). There are significant differences in the diagnosis,...
Autores principales: | Jiang, Panruo, Desai, Aakash, Ye, Haige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278675/ https://www.ncbi.nlm.nih.gov/pubmed/34256839 http://dx.doi.org/10.1186/s40164-021-00232-3 |
Ejemplares similares
-
Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017) -
Spontaneous regression of mantle cell lymphoma: a report of four cases
por: Ye, Haige, et al.
Publicado: (2018) -
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
por: Ye, Haige, et al.
Publicado: (2018) -
An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features
por: Inamdar, Arati A, et al.
Publicado: (2021) -
Dual targeting of PI3K and BCL‐2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2022)